Tag: AstraZeneca

Browse our exclusive articles!

“Anil Ravipudi Drops Exciting Updates on His Film with Chiranjeevi!”

Director Anil Ravipudi, known as one of the most...

“Box Office Storm: 8 Days of Sankranthi Magic!”

The sensational blockbuster Sankranthiki Vastunnam, directed by Anil Ravipudi...

“All Set for Dulquer’s Entry in Anupama’s ‘Parada’ Journey!”

The shooting for the much-awaited film Parada, featuring the...

‘Vishwambhara’ OTT Plans: Impact of ‘OG’

Mega hero fans are eagerly awaiting a much-needed blockbuster....

Exciting News: Naga Shaurya’s Upcoming Movie Update!

Young hero Naga Shaurya has always impressed audiences with...

“Kangana’s Strategic Decision for ‘Emergency’ Success!”

Bollywood firebrand Kangana Ranaut has directed and starred in...

“‘Venky’ Creates History in North America!”

Victory Venkatesh's latest film, Sankranthiki Vastunnam, released as a...

“‘Thandel’ All Set for a Grand Release!”

Akkineni Naga Chaitanya and Sai Pallavi's upcoming film ‘Thandel,’...

“Thaman’s Bond with NBK: The Rise of NBK Thaman!”

Nandamuri Natasimham Balakrishna’s latest film, ‘Daku Maharaj,’ released during...

“Allu Arjun’s Next Project Announcement: Don’t Miss It!”

Icon star Allu Arjun’s ‘Pushpa 2’ has set sensational...

AstraZeneca approved as booster vaccine in Australia

Australia has provisionally approved the use of the AstraZeneca vaccine against Covid-19 as a booster shot for people aged 18 years and older. However, in...

Politicians criticising AstraZeneca vax ‘killed thousands’: Scientist

Doubts cast by several scientists and politicians alike over the efficacy of the AstraZeneca Covid vaccine, developed in collaboration with the Oxford University "probably...

University of Oxford study supports use of Vaxzevria as third dose against Omicron

AstraZeneca's Vaxzevria significantly boosted levels of antibodies against the Omicron SARS-CoV-2 variant following a third dose booster, according to data from a new...

Oxford study supports AstraZeneca for third dose against Omicron

A third dose of AstraZeneca's Covid vaccine, named Covishield in India, produces similar neutralising antibody levels against Omicron as after two doses against the...

AstraZeneca’s antibody cocktail can prevent, treat Covid-19

AstraZeneca's long-acting antibody combination is both able to prevent and treat Covid-19, according to the phase three results released on Monday. The drug, AZD7442, is...

AstraZeneca to use new vax technology to treat cancer, heart disease

UK drugmaker AstraZeneca has partnered with scientists at Imperial College London to develop a new vaccine technology to treat cancer, heart conditions and other...

AstraZeneca does not raise high blood clot risk post 2nd dose: Study

The incidence of rare blood clot is higher following a Covid-19 infection than two doses of AstraZeneca or Pfizer/BioNTech vaccines, according to a new...

AstraZeneca partners with Docon to digitise healthcare clinics in India

AstraZeneca India on Wednesday signed an MoU with Bengaluru-based Docon Technologies for digitizing 1,000 clinics across India. Under the partnership, Don will equip the identified...

Mixing Covid doses may help boost immune response: Study

Taking the first dose of Pfizer Covid vaccine and then AstraZeneca for the second can provide good protection against the pandemic virus, a study...

AstraZeneca tests Covid booster shots against Beta-variant

British-Swedish biopharmaceutical firm AstraZeneca has in partnership with the University of Oxford rolled out human trials for booster shots against the Beta Covid variant. The...

Popular

“Box Office Storm: 8 Days of Sankranthi Magic!”

The sensational blockbuster Sankranthiki Vastunnam, directed by Anil Ravipudi...

“All Set for Dulquer’s Entry in Anupama’s ‘Parada’ Journey!”

The shooting for the much-awaited film Parada, featuring the...

‘Vishwambhara’ OTT Plans: Impact of ‘OG’

Mega hero fans are eagerly awaiting a much-needed blockbuster....

Exciting News: Naga Shaurya’s Upcoming Movie Update!

Young hero Naga Shaurya has always impressed audiences with...